Cerebras Systems' IPO bookbuild reached Day 5 Friday with Bloomberg's May 5 report — confirmed across the trading week — that lead bookrunners are requiring limit-only orders from institutional investors. [1] The order book stands above $10 billion in indications of interest against $3.5 billion of paper available at the $115-$125 / $26.6 billion band, roughly 3x oversubscribed. Pricing remains scheduled for May 13 (T-5), with trading May 14 (T-6) on Nasdaq under CBRS. [2] Andrew Feldman, the CEO and co-founder, is not selling shares in the offering. [3]

The May 7 paper opened the file on the bookbuild as a referendum on customer concentration with $10B+ IOIs against $3.5B offered. Today's standard advances the structural signal: the Bloomberg-confirmed limit-only requirement. Anthony Hughes and Bailey Lipschultz at Bloomberg reported on May 5 that Morgan Stanley, leading the offering, is "seeking so-called limit orders to help the company and the underwriters gauge the true level of demand at different valuations." [1] The mechanism is the bookrunner's tool for pricing discipline when oversubscription threatens to produce a market-order pile-on at the open. The mechanism's deployment is the news.

Limit-only requirements at this stage of a bookbuild signal two things at once. First, demand is strong enough that bookrunners can dictate order specificity — the order book is no longer an open invitation but a price-discovery exercise. Second, the bookrunners are prepared to leave the price at $115-$125 rather than tighten the band higher. The original chatter at Monday's open was Cerebras targeting up to $4 billion in proceeds at a $40 billion valuation; the actual S-1/A landed at $3.5 billion at $26.6 billion. The walk-back from $40B to $26.6B was a 33% valuation cut at filing. The limit-only requirement is the bookrunners protecting that cut from being overrun by trading-day volatility.

The arithmetic the limit-only mechanism prices remains the OpenAI counterparty triangle. Cerebras's 2025 booked revenue was $510 million, with $87.9 million in Q4 2025 net income. [3] At the high end of the range, the IPO values the company at roughly 78x trailing sales. The OpenAI compute agreement signed in January 2026 — 750 megawatts of inference capacity through 2028, worth more than $20 billion, with a 1.25 GW expansion option and a $1 billion working-capital loan — is the contract that closes the multiple. [3] Public filings indicate more than 60% of contracted forward Cerebras revenue is concentrated in that single customer.

The Brockman trial transcript exposure is the other documentary risk inside the prospectus window. Greg Brockman, OpenAI's president, confirmed under oath in Oakland federal court Monday that he holds a personal stake in Cerebras while serving as OpenAI's president. [4] Public filings indicate Brockman acquired the stake — reported at $2.8 million in initial value — during the period when OpenAI-Cerebras acquisition discussions were active. The prospectus risk-factor section as currently drafted catalogs OpenAI as the anchor customer but does not name Brockman individually. Whether Cerebras's lawyers update the risk-factor section to incorporate the Brockman trial transcript before pricing is a procedural question with five business days to resolve.

The bookrunner architecture matters for downside. Morgan Stanley, Citigroup, Barclays, and UBS are the four lead book-running managers. Mizuho and TD Cowen are bookrunners. Eight co-managers — Needham, Craig-Hallum, Wedbush, Rosenblatt, Academy Securities, Crédit Agricole CIB, MUFG, and First Citizens — round out the syndicate. [5] [3] No bank has pulled from the syndicate. The limit-only requirement is the four-bank consortium's collective discipline; whether any single bank breaks the discipline before May 13 is the open syndicate question.

The lockup architecture is what holds Feldman's incentive in line with the public-market price. Cerebras's 171.1 million-share lock-up runs to Q3 earnings plus 180 days. Feldman owns 10.3 million Class B shares post-IPO with 99.2% Class B voting power. [3] At the $125 high end, his stake is worth $1.28 billion at IPO. The lock-up holds him in for two more earnings cycles. The institutional buyers required to submit limit orders are pricing into a stock structure where insider control is permanent and dilution from secondary sales is constrained for the next eighteen months at minimum.

Friday's IOI book at above $10 billion against $3.5 billion of paper is, on its face, a positive signal. The limit-only requirement is the bookrunner's interpretation of that signal as needing structure. The market's read of the structure between now and Wednesday's pricing is what the next five trading days produce. CNBC reported Tiger Global is among the participants at the Series H level; sovereign-wealth participation is rumored at the $1.5 billion-plus level. [6] Names will not appear in the final allocation; the limit orders submitted into the book will determine which institutions receive what proportion of the 28 million shares offered, plus the 4.2 million-share underwriter overallotment.

Pricing T-5. Trading T-6. The Brockman risk-factor disclosure window has five business days to update before the prospectus is final. The IOI book holds above $10 billion. The CBRS open will read the limit-order discipline.

-- THEO KAPLAN, San Francisco